ANTIMICROBIAL RESISTANCE IN MALIGNANT WOUNDS IN PATIENTS IN PALLIATIVE CARE: A CROSS-CROSS STUDY
DOI:
https://doi.org/10.56238/arev7n6-104Keywords:
Wounds and lesions, Palliative care, Bacterial infections, CancerAbstract
Objective: To identify resistant bacterial strains and discuss antimicrobial resistance from the perspective of patients with malignant neoplastic wounds undergoing palliative care. Method: This is a cross-sectional, descriptive, and quantitative study carried out at the National Cancer Institute (RJ) in 2018. The sample consisted of 36 patients, with swab/antibiogram tests collected after approval by the Research Ethics Committee. The Pearson chi-square test and principal component analysis were used for statistical analysis. Results: Twelve bacterial genera with different percentages of resistance/sensitivity present in the wounds were detected: Proteus sp, E. coli sp., Acinetobacter sp., Enterobacter, Serratia sp., Klebsiella sp., Morganella sp., Staphylococcus sp., Citrobacter, Providencia, Enterococcus, and Pseudomonas sp. In the evaluation of antibiotics with greater resistance, the following were observed: ampicillin, cefoxitin and amoxicillin/clavulanate. Conclusion: It is recommended that measures be implemented to better control infections and protect patients with advanced cancer.
